DASATINIB

Generic: DASATINIB

Apotex Corp.Manufacturer
ORALRoute
DASATINIBActive Substance
2016-06-10Original Approval

DASATINIB is FDA application ANDA202103, sponsored by APOTEX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
PLEURAL EFFUSION
1,211 reports
2
DRUG INEFFECTIVE
728 reports
3
DRUG INTOLERANCE
575 reports
4
DRUG RESISTANCE
538 reports
5
DEATH
470 reports
6
DIARRHOEA
441 reports
7
THROMBOCYTOPENIA
430 reports
8
DYSPNOEA
416 reports
9
MALIGNANT NEOPLASM PROGRESSION
399 reports
10
FATIGUE
384 reports